Conférence Annuelle de l’American Society of Gene & Cell Therapy

La conférence de l'American Society of Gene & Cell Therapy se tiendra du 10 au 13 mai 2017 à Washington DC, aux États-Unis. 

Cellectis donnera une présentation orale et présentera troix posters lors de la conférence de l'American Society of Gene & Cell Therapy qui se tiendra du 10 au 13 mai 2017 à Washington DC, aux États-Unis.

Oral presentation:

Development of Gene Edited Allogeneic CAR T-Cell Therapy
Laurent Poirot, Ph.D., Head of early discovery, Cellectis

Session: 300 - Clinical Advancement of Gene Editing-Moving New Science to the Clinic -
Organized by the Clinical Trials and Regulatory Affairs Committee
Friday, May 12, 2017 from 8:35 AM to 9:10 AM EST
Lincoln 2, 3, 4

Poster presentations:

176 - Genome-Wide Analysis of TALEN® Activity in Primary Cells
Brian Busser, Sonal Temburni, Aymeric Duclert, Philippe Duchateau and Laurent Poirot

Session: Gene Targeting and Gene Correction I
Wednesday May 10, 2017 at 5:30 PM EST
Exhibit Hall A & B South

114 - UCART22: An Allogeneic Adoptive Immunotherapy for Leukemia Targeting CD22 with CAR T-cells
Anne-Sophie Gautron, Cécile Schiffer-Mannioui, Alan Marechal, Severine Thomas, Agnes Gouble, Laurent Poirot, Julianne Smith

Session: Cancer-Immunotherapy, Cancer Vaccines I
Wednesday May 10, 2017 from 5:30 PM to 7:30 PM EST
Exhibit Hall A & B South

372 - Manufacturing of Gene-Modified Mouse CAR T-Cells
Laurent Poirot, Brian Busser, Sonal Temburni, Philippe Duchateau

Session: Gene Targeting and Gene Correction II
Thursday May 11, 2017 from 5:15 PM to 7:15 PM EST
Exhibit Hall A & B South